Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion

Charles L Bevins, N. Bashirelahi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

In the presence of 10 mM molybdate ion, the authors were able to detect the appearance of a [6,7-3H]-17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione-([3H]R5020) binding moiety in human prostatic cytosol which sedimented at approximately 8S in a glycerol density gradient. The specifically bound [3H]R5020 was displaced by progesterone, triamcinolone acetonide, and R5020 but not by cortisol, dihydrotestosterone, 17β-estradiol, or diethylstilbestrol. Specific binding of [3H]R5020 in the presence of molybdate ion was shown to saturate at 7 x 10-10 M (n = 64 fmol/mg of protein). The optimum concentration of molybdate ion for enhancing specific binding of [3H]R5020 was determined to be between 7 and 20 mM. Molybdate ion was also effective in stabilizing the 8S R5020-binding moiety in a preincubation for 16 hr at 0° in the absence of added steroid.

Original languageEnglish (US)
Pages (from-to)2234-2239
Number of pages6
JournalCancer Research
Volume40
Issue number7
StatePublished - 1980
Externally publishedYes

Fingerprint

Promegestone
Progesterone Receptors
Prostate
Triamcinolone Acetonide
Diethylstilbestrol
Dihydrotestosterone
molybdate
Cytosol
Glycerol
Progesterone
Hydrocortisone
Estradiol
Steroids

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion. / Bevins, Charles L; Bashirelahi, N.

In: Cancer Research, Vol. 40, No. 7, 1980, p. 2234-2239.

Research output: Contribution to journalArticle

@article{5bce48a416fd4e2bb31f8a4ec1b2b035,
title = "Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion",
abstract = "In the presence of 10 mM molybdate ion, the authors were able to detect the appearance of a [6,7-3H]-17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione-([3H]R5020) binding moiety in human prostatic cytosol which sedimented at approximately 8S in a glycerol density gradient. The specifically bound [3H]R5020 was displaced by progesterone, triamcinolone acetonide, and R5020 but not by cortisol, dihydrotestosterone, 17β-estradiol, or diethylstilbestrol. Specific binding of [3H]R5020 in the presence of molybdate ion was shown to saturate at 7 x 10-10 M (n = 64 fmol/mg of protein). The optimum concentration of molybdate ion for enhancing specific binding of [3H]R5020 was determined to be between 7 and 20 mM. Molybdate ion was also effective in stabilizing the 8S R5020-binding moiety in a preincubation for 16 hr at 0° in the absence of added steroid.",
author = "Bevins, {Charles L} and N. Bashirelahi",
year = "1980",
language = "English (US)",
volume = "40",
pages = "2234--2239",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion

AU - Bevins, Charles L

AU - Bashirelahi, N.

PY - 1980

Y1 - 1980

N2 - In the presence of 10 mM molybdate ion, the authors were able to detect the appearance of a [6,7-3H]-17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione-([3H]R5020) binding moiety in human prostatic cytosol which sedimented at approximately 8S in a glycerol density gradient. The specifically bound [3H]R5020 was displaced by progesterone, triamcinolone acetonide, and R5020 but not by cortisol, dihydrotestosterone, 17β-estradiol, or diethylstilbestrol. Specific binding of [3H]R5020 in the presence of molybdate ion was shown to saturate at 7 x 10-10 M (n = 64 fmol/mg of protein). The optimum concentration of molybdate ion for enhancing specific binding of [3H]R5020 was determined to be between 7 and 20 mM. Molybdate ion was also effective in stabilizing the 8S R5020-binding moiety in a preincubation for 16 hr at 0° in the absence of added steroid.

AB - In the presence of 10 mM molybdate ion, the authors were able to detect the appearance of a [6,7-3H]-17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione-([3H]R5020) binding moiety in human prostatic cytosol which sedimented at approximately 8S in a glycerol density gradient. The specifically bound [3H]R5020 was displaced by progesterone, triamcinolone acetonide, and R5020 but not by cortisol, dihydrotestosterone, 17β-estradiol, or diethylstilbestrol. Specific binding of [3H]R5020 in the presence of molybdate ion was shown to saturate at 7 x 10-10 M (n = 64 fmol/mg of protein). The optimum concentration of molybdate ion for enhancing specific binding of [3H]R5020 was determined to be between 7 and 20 mM. Molybdate ion was also effective in stabilizing the 8S R5020-binding moiety in a preincubation for 16 hr at 0° in the absence of added steroid.

UR - http://www.scopus.com/inward/record.url?scp=0018836207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018836207&partnerID=8YFLogxK

M3 - Article

C2 - 7190061

AN - SCOPUS:0018836207

VL - 40

SP - 2234

EP - 2239

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -